Tuesday, June 19, 2018
 
 
Company News: Page (1) of 1 - 02/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Antibiotics developer Octagon Therapeutics closes financing, adds thought leaders
 
(February 13, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Science,Lifestyle,Medical,Biology,Cancer,Family,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Suomen Hoivatilat Oyj: New business concepts
  • Global 3D Medical Imaging Industry
  • Michael A. Smith, MD promoted to director of education at Life Extension
  • Cardiac Pacemaker Market to be Worth US$ 11.1 Billion by 2026
  • Global Cosmetic Antioxidants Market Forecast to 2023: Market is Driven by a Rise in Aging Population, Increasing Disposable Income, and Changing Lifestyle

    Cancer
  • Celyad Doses First AML Patient at Final Dose Level in CYAD-01 THINK Trial and Begins Dosing First Patient With Second Cycle of Therapy
  • Yoichiro Ito, MD, Recognized for Development of Cancer Chemical Separation Method
  • Citius Announces United States Patent & Trademark Office Registered the Company's Mino-Lok® Trademark
  • Avantis Medical Names Matt Frushell as President and CEO, Salmaan Hameed as CTO, as Company Moves to Full Commercial Operation
  • Pharmaceutical Glass Packaging Market Worth $22.05 Billion by 2025: Grand View Research, Inc.
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines